Trial intelligence / Profile preview

Fentanyl dose for non-paralytic tracheal intubation in pediatric tonsillectomy

ChiCTR2300072803Phase 4Recruiting

Sponsor
The First Hospital of Fujian Medical University
Start
Jun 2023
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of fentanyl in primary snoring and Tonsillar hyperplasia (3 arms), sponsored by The First Hospital of Fujian Medical University. Primary endpoints: Intubation conditions and Recovery time for spontaneous respiration. Started Jun 2023; status: recruiting.

02

Drugs

fentanyl
03

Conditions

primary snoringTonsillar hyperplasia

Beyond the preview

Go deeper on ChiCTR2300072803.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300072803.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call